Oncodaily·2 min read·hard
Network Approach for ctDNA Profiling in Breast Cancer
S
Susanna Baghdasaryan
✦AI Summary
Researchers have developed ALFAssay, a neural-network-based tool that uses shallow whole-genome sequencing to detect circulating tumor DNA (ctDNA) in breast cancer patients. The study demonstrates high sensitivity and specificity, suggesting potential for improved liquid biopsy diagnostics.
Michail Ignatiadis , Director, Breast Medical Oncology Clinic and Program at Institut Jules Bordet, shared on LinkedIn :
sciencehealthtechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in